BioLingus (Cayman) Limited (SUBL)

BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.

IPO Price

$20.00

Shares Offered

360,000

Deal Size

$7.20M

SUBL Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	Current	2022	2021
Market Capitalization	222	-	-
Enterprise Value	229	-	-
Debt / Equity Ratio	-0.83	-0.87	-0.83
Debt / EBITDA Ratio	-24.29	-6.23	-3.10
Debt / FCF Ratio	-19.42	-12.00	-3.20
Quick Ratio	0.01	0.04	0.05
Interest Coverage	-1.69	-6.10	-17.52
Return on Equity (ROE)	7.64%	18.54%	31.91%
Return on Assets (ROA)	-	-397.82%	-272.87%
Return on Capital (ROIC)	47.51%	132.43%	174.81%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).